MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Sleep quality in Turkish patients with Parkinson’s disease

E. Tur, M. Demir, G. Kenangil, F. Domaç (Istanbul, Turkey)

Meeting: 2019 International Congress

Abstract Number: 598

Keywords: Pittsburgh Sleep Quality Index(PSQI), Sleep disorders. See also Restless legs syndrome: Clinical features

Session Information

Date: Monday, September 23, 2019

Session Title: Restless Leg Syndrome, RBD and Other Sleep Disorders

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: The aim of our study is to investigate the quality of sleep and the prevalence of excessive daytime sleepness(EDS) and nighttime problems in patients with Parkinson disease

Background: Sleep disorders are common nonmotor symptoms that affects quality of life patients with Parkinson’s disease(PD). Sleep disturbances and excessive daytime sleepiness in Parkinson’s disease are caused by multi-factorial etiologies, including dopaminergic medication, disease itself, concomittant depression, sleep-wake distruptions.

Method: A total of 140 patient who have been diagnosed with PD according to UK Parkinson’s Disease Society Brain Bank (UKPDS) criteria and 75 healty control have been included in the study. The clinical staging of PD was performed with Modified Hoehn&Yahr Staging Scale (HYS),  the measurement of clinical severity was performed with Unified Parkinson’s Disease Rating Scale (UPDRS), sleep quality was performed with Parkinson’s Disease Sleep Scale(PDSS), the Pittsburg Sleep Quality İndex(PSQI) and the Epword Sleepness Scale(ESS). Participants were also evaluated for their subjective levels of depression using the Beck’s Depression invertory.

Results: Hoehn and Yahr staging was 1,98±0,8 and UPDRS scales 35,1±17,9 in the 140 patients(%56,6 male, mean age 64,9±10,8 years and disease duration 6,38±5,31 years). The PSQI scale, ESS and Beck Depression Scale was significantly higher in patient group compared to control group. PD patient with poor sleep quality(PSQI>5) was %66,4 and EDS(ESS>10) was %17,1. According to evaluations of PDSS subgroups; the poor sleepers had lower scores for sleep quality, insomnia, nocturnal restless, nocturia and  sleep refreshment. EDS was possitively correlated with levodopa exposure time, Levodopa equivalent dosage, Beck Depression scores and was also negativly correlated nocturnal restless, nocturia, nocturnal psychosis, daytime dozing.

Conclusion: In our study, depression and EDS were higher and sleep quailty was lower rates in Parkinson’s patients compared to controls. In subgroup examination of PDSS, it was observed that decrease in sleep quality and EDS occured due to different etiological reasons. We believe that treatment for the reason of sleep disorder will increase treatment success and functionality in Parkinson’s patients.

To cite this abstract in AMA style:

E. Tur, M. Demir, G. Kenangil, F. Domaç. Sleep quality in Turkish patients with Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/sleep-quality-in-turkish-patients-with-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sleep-quality-in-turkish-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley